Abstract:Objective The study was to explore the serotonergic and dopeminergic function in centralnervous system and to determine the pharmacological mechanisms of typical and atypical antipsychotics. Methods78 inpatients with schizophrenia were treated with a fixed dose of risperidone 6 mg daily or haloperidol 20 mg perday for 12-week in a double-blind, randomized design. The symptoms were evaluated by PANSS before and aftertreatment. Prolactin and cortisol responses to paroxetine challenge test were measured at pre- and post-treatment,as compared with 18 normal controls. Results At pre-treatment, baseline cortisol level and paroxetine-evokedcortisol response was significantly higher but baseline prolactin level was significantly lower paroxetine-stimulatedprolactin level in patient group. After treatment, the baseline prolactin levels of patients in both risperidone andhaloperidol groups were significantly increased and higher than that of normal control. No difference in prolactinresponse to paroxetine stimulation was noted between risperidone and haloperidol groups. Baseline cortisol levelswere markedly lower in both treatment groups than before treatment but a significant reduction for risperidonegroup. There was a significant decrease in cortisol response to paxoxetine challenge test in risperidone treatmentgroup but no difference in haloperidol treatment group when compared with both before treatment and normalcontrol. Conclusions The hyperactivity of dopamine and serotonin function may exist in patients withschizophrenia before treatment. Risperidone treatment can reduce the elevated 5-HT function of patient to normallevel. But haloperidol treatment doesn't produce significant influence on 5-HT function. Both risperidone andhaloperidol can ichibit the dopamine function considerably in the central nervous system.

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects

Effects of Meta-Chlorophenylpiperazine on Neuroendocrine and Behavioral Responses in Male Schizophrenic Patients and Normal Volunteers

Behavioral Indications for Serotonin Receptor Hypersensitivity in Panic Disorder

Functional interrelationship of serotonin and norepinephrine: Cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects

Serotonin Function in Schizophrenia: Effects of Meta- Chlorophenylpiperazine in Schizophrenia Patients and Healthy Subjects

Pindolol Pretreatment Blocks Stimulation by Meta-Chlorophenylpiperazine of Prolactin but Not Cortisol Secretion in Normal Men

Effect of M-Chlorophenylpiperazine on Plasma Homovanillic Acid Concentrations in Healthy Subjects

Sex‐linked Differences in Cortisol, ACTH and Prolactin Responses to 5‐hydroxy‐tryptophan in Healthy Controls and Minor and Major Depressed Patients

A control study of gonadal hormone level in female patients with panic disorder

Effect of Pindolol Pretreatment on Mk-212-Induced Plasma-Cortisol and Prolactin Responses in Normal Men

Salivary Cortisol in Panic: Are Males More Vulnerable?

Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers

Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic

Poster #M76 AN OPEN-LABEL, FLEXIBLE-DOSE STUDY OF PALIPERIDONE EXTENDED RELEASE IN CHINESE PATIENTS WITH FIRST-ONSET PSYCHOSIS

Anxious behavior and fenfluramine-induced prolactin secretion in young rhesus macaques with different alleles of the serotonin reuptake transporter polymorphism (5HTTLPR)

Effects of experimental panic on neuroimmunological functioning

Psychomotor Slowing, Neuroendocrine Responses, and Behavioral Changes after Oral Administration of Meta-Chlorophenylpiperazine in Normal Volunteers

Effects of antidepressant on FKBP51 mRNA expression and neuroendocrine hormones in patients with panic disorder

Clozapine Treatment and Its Effect on Neuroendocrine Responses Induced by the Serotonin Agonist, M-Chlorophenylpiperazine

Effects of Risperidone and Haloperidol on Paroxetine-Evoked Neuroendocreine Responses in Schizophrenia

Pituitary and adrenal hormone responsiveness to Synachten in melancholic subjects versus subjects with minor depression